Patients with COVID-19 also had higher expression of HLA-DRhigh on IL-22R1+ pDC compared to their IL-22R1neg cells, but this higher expression was also observed in controls suggesting that this IL-22R1 related activation pattern is not restricted to SARS-CoV-2 infection. The gene discussed is IL22RA1; the disease is COVID-19.